Cancer Treatment

AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for infusion used in cancer treatment for an additional indication. The company has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, to import for sale and distribution of Durvalumab solution for infusion of strengths 120 mg/2.4 ml and 500 mg/10 ml (brand name Imfinzi) for an additional indication, AstraZeneca Pharma said in a regulatory filing. Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab as monotherapy in endometrial cancer which is mismatch repair deficient (dMMR). The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 1

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities

A machine learning study has flagged more than 260,000 cancer research papers worldwide as potentially linked to paper mills, raising serious concerns about the reliability and integrity of cancer sci

World Cancer Day 2026: Being declared cancer-free does not always mean full recovery, as oncologists explain why life after cancer often involves lasting physical, mental and emotional effects

World Cancer Day 2026 marks February 4 with the theme 'United by Unique', tracing the day's history and underlining why prevention, screening and equitable access to cancer care matter worldwide

Scientists in Spain have reported a promising pancreatic cancer breakthrough in mice, where a triple-drug therapy eliminated tumours by targeting the KRAS pathway, one of deadliest cancer mechanisms

A state-funded cancer research project centred on cow-based remedies has triggered debate. Surgical oncologist explains what science says, what evidence is missing, and why accountability matters

A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition

What if a single vaccine platform could train the immune system to prevent multiple cancers? A new nanoparti

Servier is stepping up its India push to bring first-in-class and precision medicines, expand global clinical research participation and use India for manufacturing and GCC services

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 mutation once seen as essential, shifting cure research

Once seen as a disease of the wealthy, cancer now affects all regions, with a growing share of cases and deaths occurring in low- and middle-income countries

Cancers of the respiratory system ranked fifth in India in 2022, with 1,43,062 reported cases. Digestive system cancers and breast cancer remained the top sites.

Scientists have found that Covid-19 mRNA vaccines could enhance immune responses in cancer patients, potentially transforming how immunotherapy works

Women's cancers like breast, cervical, and ovarian are often detected late in poorer countries, sharply reducing survival chances, according to a global Lancet study

India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study. Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden. However, researchers, including those from the the Latin American Cooperative Oncology Group, said that clinical trials of cancer are disproportionally concentrated in high-income countries, even as previous evidence suggests an increase in trials among low and middle-income nations. The study, published in the journal 'CANCER', looked at disparities in the numbers and complexity of clinical trials over time and according to economic changes. Datasets from World Bank and ClinicalTrials.gov were analysed. Between 2001 and 2020, a total of 16,977 can

The facility, funded through ICICI Bank's CSR arm, will house advanced radiation equipment and serve thousands of cancer patients annually at Tata Memorial's Navi Mumbai campus

Scientists have developed a new light-based therapy using tin nanoflakes and LED light to kill up to 92% of cancer cells while sparing healthy tissue, offering hope for safer, home-based treatment

The agreement gives Glenmark exclusive rights to develop and commercialise cancer drug Trastuzumab Rezetecan outside China, the US, Europe, and other select markets

A new study reveals that glucose not only fuels energy but also equips immune T cells with tools to better organise and destroy cancer cells